Procyon Advisors’s Prothena Corp PRTA Stock Holding History

Procyon Advisors’s Portfolio PRTA Stock Details PRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-9	Closed	–	–	831
2020 Q2	$0	Hold	9	–	–	﹤0.01%	1167
2020 Q1	$0	Hold	9	–	–	﹤0.01%	1122
2019 Q4	$0	Buy	+9	New	+$97	﹤0.01%	1052

Other funds holding PRTA

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Procyon Advisors's PRTA Position: Q3 2020 in Review

Procyon Advisors sold out of Prothena Corp (PRTA) in Q3 2020, closing a stake of 9 shares.

Procyon Advisors first reported a position in PRTA in Q4 2019 and held it in 3 quarters. The position peaked at $0 in Q2 2020. 140 funds tracked by Wall St. Rank hold PRTA as of Q3 2020.

Procyon Advisors reported no remaining Prothena Corp position as of Q3 2020 after selling out during the quarter.
Procyon Advisors sold 9 Prothena Corp shares in Q3 2020.
Procyon Advisors first reported a position in Prothena Corp in Q4 2019 and held it in 3 quarters.
Procyon Advisors's Prothena Corp position peaked at $0 in Q2 2020.
140 funds tracked by Wall St. Rank held Prothena Corp as of Q3 2020.

Based on Procyon Advisors's 13F filing for Q3 2020, filed 22 Oct 2020.